| The 97th Annual Meeting of the American Society for Microbiology. | |
| | |
MedLine Citation:
|
PMID: 15989653 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
The Annual Meeting of the American Society for Microbiology took place in Miami Beach, Florida, from May 4-8, 1997. Over 9000 scientists attended this meeting, which covers all major aspects of prokaryotic research (basic, applied, medical, and diagnostic). Genomics discussions were a major part of the meeting agenda, with scientists detailing both basic and applied research effort using genomics and bioinformatics. New ideas for potential novel antimicrobials have also surfaced as the tools to pursue Drug Discovery have fallen into place and pharmaceutical companies have ;rediscovered' anti-infectives. |
| | |
Authors:
|
M Frosco; M J Pucci; L Licata; L E Lawrence; L F Discotto; B Ryan; B D Foleno; M Loeloff; J F Barrett |
Related Documents
:
|
14680473 - 18th annual scientific meeting of the international society for biological therapy of c... 8533113 - Method and methodology in medical ethics: inaugurating another new section. 21510133 - The right to secure food in the perspective of the general improvement of the fundament... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert opinion on investigational drugs Volume: 6 ISSN: 1744-7658 ISO Abbreviation: Expert Opin Investig Drugs Publication Date: 1997 Jul |
Date Detail:
|
Created Date: 2005-07-01 Completed Date: 2005-07-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9434197 Medline TA: Expert Opin Investig Drugs Country: England |
Other Details:
|
Languages: eng Pagination: 899-13 Citation Subset: - |
Affiliation:
|
The RW Johnson Pharmaceutical Research Institute, Raritan, NJ 08869, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Psoriasis: latest advances in understanding and novel therapeutic approaches.
Next Document: Drugs for cardiovascular disease. Spoilt for choice?